×
The Standard e-Paper
Join Thousands Daily
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
WELLINGTON: Obesity could hinder the effects of a common drug that is used as part of a treatment to fight breast cancer in post-menopausal women, New Zealand scientists said Wednesday.
Aromatase inhibitor (AI) drugs stopped the production of oestrogen which stimulated the growth of hormone-receptor-positive breast cancer cells, but they could be less effective in obese women because of the greater quantity of aromatase in peripheral fatty tissue, said Auckland University cancer epidemiologist Professor Mark Elwood.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
join